Depakine

News

Sanofi has said that it will donate 10 million Euros to the rebuilding of Notre Dame cathedral in Paris, prompting a mixed response from the public.

News

Neuraxpharm and Minoryx' Nezglyal has become the first approved drug therapy in the EU for rare neurodegenerative disease cALD.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.